AAAAAA

   
Results: 1-12 |
Results: 12
ALPHA-BLOCKADE THERAPY FOR BENIGN PROSTATIC HYPERPLASIA - FROM A NONSELECTIVE TO A MORE SELECTIVE ALPHA(1A)-ADRENERGIC ANTAGONIST
Authors: BEDUSCHI MC BEDUSCHI R OESTERLING JE
Citation: Mc. Beduschi et al., ALPHA-BLOCKADE THERAPY FOR BENIGN PROSTATIC HYPERPLASIA - FROM A NONSELECTIVE TO A MORE SELECTIVE ALPHA(1A)-ADRENERGIC ANTAGONIST, Urology, 51(6), 1998, pp. 861-872
TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE - A MINIMALLY INVASIVE TREATMENT FOR SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA
Authors: BEDUSCHI MC OESTERLING JE
Citation: Mc. Beduschi et Je. Oesterling, TRANSURETHRAL NEEDLE ABLATION OF THE PROSTATE - A MINIMALLY INVASIVE TREATMENT FOR SYMPTOMATIC BENIGN PROSTATIC HYPERPLASIA, Mayo Clinic proceedings, 73(7), 1998, pp. 696-701
PERCENT FREE PSA DISTRIBUTION IN MALE POPULATIONS WITH NORMAL AND ABNORMAL PROSTATE EVALUATIONS - DETERMINATION OF REFERENCE RANGES
Authors: BEDUSCHI MC BEDUSCHI R VASHI A PUTZI M GIACHERIO DA ENGLAND BE WOJNO K MONTIE JE
Citation: Mc. Beduschi et al., PERCENT FREE PSA DISTRIBUTION IN MALE POPULATIONS WITH NORMAL AND ABNORMAL PROSTATE EVALUATIONS - DETERMINATION OF REFERENCE RANGES, The Journal of urology, 159(5), 1998, pp. 892-892
BENIGN PROSTATIC HYPERPLASIA - USE OF DRUG-THERAPY IN PRIMARY-CARE
Authors: BEDUSCHI R BEDUSCHI MC OESTERLING JE
Citation: R. Beduschi et al., BENIGN PROSTATIC HYPERPLASIA - USE OF DRUG-THERAPY IN PRIMARY-CARE, Geriatrics, 53(3), 1998, pp. 24
THE USE OF A 3RD-GENERATION CHEMILUMINESCENT PSA ASSAY FOR THE EARLY DETECTION OF RECURRENT PROSTATE-CANCER
Authors: VALLOROSI CJ GIACHERIO DA BEDUSCHI MC ENGLAND BG MONTIE JE WOJNO KJ
Citation: Cj. Vallorosi et al., THE USE OF A 3RD-GENERATION CHEMILUMINESCENT PSA ASSAY FOR THE EARLY DETECTION OF RECURRENT PROSTATE-CANCER, Clinical chemistry, 44, 1998, pp. 162-162
MOLECULAR-FORMS OF PSA
Authors: BEDUSCHI MC OESTERLING JE
Citation: Mc. Beduschi et Je. Oesterling, MOLECULAR-FORMS OF PSA, Aktuelle Urologie, 29(5), 1998, pp. 221-231
STAGE T1C PROSTATE-CANCER - DEFINING THE APPROPRIATE STAGING EVALUATION AND THE ROLE FOR PELVIC LYMPHADENECTOMY
Authors: BEDUSCHI MC BEDUSCHI R OESTERLING JE
Citation: Mc. Beduschi et al., STAGE T1C PROSTATE-CANCER - DEFINING THE APPROPRIATE STAGING EVALUATION AND THE ROLE FOR PELVIC LYMPHADENECTOMY, World journal of urology, 15(6), 1997, pp. 346-358
AN EXPERIMENTAL-MODEL FOR THE MEASUREMENT OF RENAL-FUNCTION AFTER TEMPORARY URETERAL OBSTRUCTION IN THE RAT
Authors: TUCCI S BEDUSCHI MC MAZZETTO SA VANNI JC
Citation: S. Tucci et al., AN EXPERIMENTAL-MODEL FOR THE MEASUREMENT OF RENAL-FUNCTION AFTER TEMPORARY URETERAL OBSTRUCTION IN THE RAT, Brazilian journal of medical and biological research, 30(7), 1997, pp. 855-860
PROSTATE-SPECIFIC ANTIGEN DENSITY
Authors: BEDUSCHI MC OESTERLING JE
Citation: Mc. Beduschi et Je. Oesterling, PROSTATE-SPECIFIC ANTIGEN DENSITY, Urologic clinics of North America, 24(2), 1997, pp. 323
CHANGES IN FREE PSA AND PERCENT FREE PSA OVER TIME IN A HEALTHY MALE-POPULATION
Authors: ENGLAND BG WOJNO KJ GIACHERIO DA BEDUSCHI MC CONSOLINO CM OESTERLING JE MOHR BA YURGALEVITCH S MCKINLAY J
Citation: Bg. England et al., CHANGES IN FREE PSA AND PERCENT FREE PSA OVER TIME IN A HEALTHY MALE-POPULATION, Clinical chemistry, 43, 1997, pp. 601-601
FINASTERIDE THERAPY DOES DOES SIGNIFICANTLY ALTER THE PERCENT FREE PSA VALUE BUT DECREASES FREE AND TOTAL SERUM PSA CONCENTRATIONS BY 50 PERCENT
Authors: GIACHERIO DA WOJNO KJ BEDUSCHI MC ENGLAND BG OESTERLING JE GORMLEY GJ BACH MA WALDSTREICHER J
Citation: Da. Giacherio et al., FINASTERIDE THERAPY DOES DOES SIGNIFICANTLY ALTER THE PERCENT FREE PSA VALUE BUT DECREASES FREE AND TOTAL SERUM PSA CONCENTRATIONS BY 50 PERCENT, Clinical chemistry, 43, 1997, pp. 605-605
FINASTERIDE THERAPY DOES NOT SIGNIFICANTLY ALTER THE PERCENT FREE PSAVALUE BUT DECREASES FREE AND TOTAL SERUM PSA CONCENTRATIONS BY 50 PERCENT
Authors: GIACHERIO DA WOJNO KJ BEDUSCHI MC ENGLAND BG OESTERLING JE GORMLEY GJ BACH MA WALDSTREICHER J
Citation: Da. Giacherio et al., FINASTERIDE THERAPY DOES NOT SIGNIFICANTLY ALTER THE PERCENT FREE PSAVALUE BUT DECREASES FREE AND TOTAL SERUM PSA CONCENTRATIONS BY 50 PERCENT, Clinical chemistry, 43, 1997, pp. 606-606
Risultati: 1-12 |